1. Alemtuzumab is effective against severe chronic lymphocytic leukaemia‐associated paraneoplastic pemphigus. (13th August 2013) Authors: Bech, R.; Baumgartner‐Nielsen, J.; Peterslund, N.A.; Steiniche, T.; Deleuran, M.; d'Amore, F. Journal: British journal of dermatology Issue: Volume 169:Number 2(2013:Aug.) Page Start: 469 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗